In vitro study demonstrates FGF2-dependent mineralization on titanium via a TGF-β1–osteopontin complex in human perivascular cells, suggesting mechanisms for enhanced bone graft osteogenesis.
Purpose Bioactive factors retained within the bone matrix contribute to bone regeneration; however, the mechanisms underlying their retention remain unclear. This study investigated BMP- and TGF-β–like activities in demineralized bone extracts, identified the non-collagenous proteins (NCPs) responsible for these activities, and evaluated their osteogenic potential. Methods Bone proteins were extracted from rat femora and tibiae and subsequently fractionated. BMP- and TGF-β–like activities were evaluated using alkaline phosphatase and luciferase reporter assays, respectively. Major acidic NCPs were identified using mass spectrometry, and TGF-β1 was quantified using enzyme-linked immunosorbent assay (ELISA). The molecular species of the major NCPs were further separated, and their association with TGF-β1 was analyzed using heterologous sandwich ELISA. Finally, the mineralization-inducing activity of the major NCP fraction was evaluated using human umbilical cord perivascular cells (HUCPVCs). Results BMP- and TGF-β–like activities were detected in all bone extract fractions. Mass spectrometry identified osteopontin (OPN) as the predominant NCP in the fraction exhibiting the highest TGF-β–like activity. Luciferase reporter assays confirmed TGF-β receptor–dependent transcriptional activity. ELISA detected that TGF-β1 was associated with both the 60 kDa and 64 kDa OPN molecular species. Notably, the OPN-rich fraction containing TGF-β1 promoted fibroblast growth factor 2 (FGF2)-dependent mineralization of HUCPVCs on titanium discs. Conclusions Demineralized bone matrix contains biologically active TGF-β1 associated with specific OPN molecular species. The OPN-rich fraction containing TGF-β1 exhibited FGF2-dependent osteogenic activity, suggesting that this association contributes to the osteogenic properties of bone graft materials used for bone regeneration and implant therapy.
No takes yet. Share an insight, caveat, or question.
Kohri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: